These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 23040234)

  • 41. Pneumococcal serotype distribution in invasive paediatric disease in Southern Finland before the introduction of vaccine.
    Laitinen S; Vaara M; Salo E
    Scand J Infect Dis; 2010 Dec; 42(11-12):924-30. PubMed ID: 20735331
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine.
    Pilishvili T; Lexau C; Farley MM; Hadler J; Harrison LH; Bennett NM; Reingold A; Thomas A; Schaffner W; Craig AS; Smith PJ; Beall BW; Whitney CG; Moore MR;
    J Infect Dis; 2010 Jan; 201(1):32-41. PubMed ID: 19947881
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the intermountain west: emergence of nonvaccine serogroups.
    Byington CL; Samore MH; Stoddard GJ; Barlow S; Daly J; Korgenski K; Firth S; Glover D; Jensen J; Mason EO; Shutt CK; Pavia AT
    Clin Infect Dis; 2005 Jul; 41(1):21-9. PubMed ID: 15937758
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines.
    Isaacman DJ; McIntosh ED; Reinert RR
    Int J Infect Dis; 2010 Mar; 14(3):e197-209. PubMed ID: 19700359
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Epidemiological features of invasive pneumococcal disease before and after the introduction of pneumococcal conjugate vaccine in Gran Canaria (Canary Islands)].
    Artiles F; Horcajada I; Cañas AM; Alamo I; Bordes A; González A; Santana M; Lafarga B
    Enferm Infecc Microbiol Clin; 2009 Jan; 27(1):14-21. PubMed ID: 19217998
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bacteremic pneumococcal community-acquired pneumonia in children less than 5 years of age in Italy.
    Esposito S; Marchese A; Tozzi AE; Rossi GA; Da Dalt L; Bona G; Pelucchi C; Schito GC; Principi N;
    Pediatr Infect Dis J; 2012 Jul; 31(7):705-10. PubMed ID: 22426300
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Non-susceptibility trends and serotype coverage by conjugate pneumococcal vaccines in a Tunisian paediatric population: a 10-year study.
    Charfi F; Smaoui H; Kechrid A
    Vaccine; 2012 Dec; 30 Suppl 6():G18-24. PubMed ID: 23228353
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pneumococcal Pneumonia Requiring Hospitalization in US Children in the 13-Valent Pneumococcal Conjugate Vaccine Era.
    Olarte L; Barson WJ; Barson RM; Romero JR; Bradley JS; Tan TQ; Givner LB; Hoffman JA; Lin PL; Hultén KG; Mason EO; Kaplan SL
    Clin Infect Dis; 2017 Jun; 64(12):1699-1704. PubMed ID: 28199482
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hospital-based surveillance of invasive pneumococcal disease among young children in urban Nepal.
    Williams EJ; Thorson S; Maskey M; Mahat S; Hamaluba M; Dongol S; Werno AM; Yadav BK; Shah AS; Kelly DF; Adhikari N; Pollard AJ; Murdoch DR
    Clin Infect Dis; 2009 Mar; 48 Suppl 2():S114-22. PubMed ID: 19191606
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Serotype 6C is associated with penicillin-susceptible meningeal infections in human immunodeficiency virus (HIV)-infected adults among invasive pneumococcal isolates previously identified as serotype 6A in South Africa.
    du Plessis M; von Gottberg A; Madhi SA; Hattingh O; de Gouveia L; Klugman KP;
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 1():S66-70. PubMed ID: 18723328
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Geographic variation in invasive pneumococcal disease following pneumococcal conjugate vaccine introduction in the United States.
    Rosen JB; Thomas AR; Lexau CA; Reingold A; Hadler JL; Harrison LH; Bennett NM; Schaffner W; Farley MM; Beall BW; Moore MR;
    Clin Infect Dis; 2011 Jul; 53(2):137-43. PubMed ID: 21690620
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Decline in the incidence of invasive pneumococcal disease at a medical center in Taiwan, 2000-2012.
    Lai CC; Lin SH; Liao CH; Sheng WH; Hsueh PR
    BMC Infect Dis; 2014 Feb; 14():76. PubMed ID: 24512501
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Necrotizing pneumonia caused by nanC-carrying serotypes is associated with pneumococcal haemolytic uraemic syndrome in children.
    Janapatla RP; Hsu MH; Hsieh YC; Lee HY; Lin TY; Chiu CH
    Clin Microbiol Infect; 2013 May; 19(5):480-6. PubMed ID: 22591179
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pulmonary complications of pneumococcal community-acquired pneumonia: incidence, predictors, and outcomes.
    Cillóniz C; Ewig S; Polverino E; Muñoz-Almagro C; Marco F; Gabarrús A; Menéndez R; Mensa J; Torres A
    Clin Microbiol Infect; 2012 Nov; 18(11):1134-42. PubMed ID: 22044658
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Serotyping and multilocus sequence typing of Streptococcus pneumoniae isolates from the blood and posterior nares of Japanese children prior to the introduction of 7-valent pneumococcal conjugate vaccine.
    Oishi T; Wada A; Chang B; Toyabe S; Uchiyama M
    Jpn J Infect Dis; 2011; 64(4):341-4. PubMed ID: 21788714
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Population-based surveillance for invasive pneumococcal disease and pneumonia in infants and young children in Bogotá, Colombia.
    Benavides JA; Ovalle OO; Salvador GR; Gray S; Isaacman D; Rodgers GL
    Vaccine; 2012 Aug; 30(40):5886-92. PubMed ID: 22484295
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Distribution of Streptococcus pneumoniae serotypes that cause parapneumonic empyema in Turkey.
    Ceyhan M; Ozsurekci Y; Gürler N; Ozkan S; Sensoy G; Belet N; Hacimustafaoglu M; Celebi S; Keser M; Dinleyici EC; Alhan E; Baki A; Oner AF; Uzun H; Kurugol Z; Aycan AE; Gurbuz V; Karadag Oncel E; Celik M; Ozkaya Parlakay A
    Clin Vaccine Immunol; 2013 Jul; 20(7):972-6. PubMed ID: 23637041
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Early trends for invasive pneumococcal infections in children after the introduction of the 13-valent pneumococcal conjugate vaccine.
    Kaplan SL; Barson WJ; Lin PL; Romero JR; Bradley JS; Tan TQ; Hoffman JA; Givner LB; Mason EO
    Pediatr Infect Dis J; 2013 Mar; 32(3):203-7. PubMed ID: 23558320
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Age- and serotype-specific pediatric invasive pneumococcal disease: insights from systematic surveillance in Santiago, Chile, 1994--2007.
    Lagos R; Muñoz A; San Martin O; Maldonado A; Hormazabal JC; Blackwelder WC; Levine MM
    J Infect Dis; 2008 Dec; 198(12):1809-17. PubMed ID: 18959497
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Five-fold increase in pediatric parapneumonic empyema since introduction of pneumococcal conjugate vaccine.
    Hendrickson DJ; Blumberg DA; Joad JP; Jhawar S; McDonald RJ
    Pediatr Infect Dis J; 2008 Nov; 27(11):1030-2. PubMed ID: 18845981
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.